| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 04/02/2009 | US20090088467 Vitamin e supplementation to tetanus toxoid |
| 04/02/2009 | US20090087916 Assay method for identifying drug candidate |
| 04/02/2009 | US20090087387 (4aR,7S,7aR)-3-methoxy-4,7-dimethylhexahydrocyclopenta[c]pyran-1(3H)-one, useful as repellents for insects and arthropods |
| 04/01/2009 | EP2042563A1 Photocurable coating composition, and overprint and process for producing same |
| 04/01/2009 | EP1664012B1 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics |
| 04/01/2009 | CN101397287A Method for preparing 4,4,5,5-dinaphthalene tetracarboxylic acid dianhydride |
| 04/01/2009 | CN101396020A Preparation method of composition containing dihydro nepetalactone |
| 03/31/2009 | US7510736 Using temperature variation to isolate epigallocatechin (EGC) and epigallocatechin gallate (EGCG) from green and/or white tea |
| 03/31/2009 | CA2436125C Synthesis of beta-lapachone and its intermediates |
| 03/31/2009 | CA2396734C Extraction of flavonoids |
| 03/31/2009 | CA2328368C Anti-inflammatory agents |
| 03/26/2009 | WO2009038089A1 Anti-fatigue agent comprising sesamin and vitamin-e |
| 03/26/2009 | WO2009036656A1 Coumarin derivatives, preparation processes and uses thereof |
| 03/26/2009 | US20090082430 Materials and Methods for Treating Coagulation Disorders |
| 03/26/2009 | US20090082285 Adiponectin expression promoter |
| 03/26/2009 | US20090081722 Site-specific labeling of affinity tags in fusion proteins |
| 03/25/2009 | EP2038241A1 Electroluminescent polymers and use thereof |
| 03/25/2009 | EP1460999B1 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 03/25/2009 | CN101391990A Method for extraction and purification of EGCG from fresh or dry tea-leaf |
| 03/25/2009 | CN100471851C Lignin in dandelion, its bacteria-resisting activity and use for medicine |
| 03/25/2009 | CN100471850C Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidative activity |
| 03/24/2009 | US7507860 Androgen modulators |
| 03/24/2009 | US7507837 Process for performing an isolated Pd(II)-mediated oxidation reaction |
| 03/24/2009 | US7507831 Therapy for breast cancer; plant extracts; 4-[(2-benzothiazolyl)thio]-5,7,3',4'-tetra-O-benzyl-epicatechin, 4-[(2-benzothiazolyl)thio]-5,7,3',4'-tetra-O-benzyl-catechin, 4-[(2-benzothiazolyl)thio]-3-O-acetyl-5,7,3',4'-tetra-O-benzyl-epicatechin |
| 03/24/2009 | US7507762 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2009 | US7507761 Benzopyran derivatives, method of production and use thereof |
| 03/24/2009 | US7507423 Extraction of flavonoids |
| 03/24/2009 | US7507395 Include pH-sensitive fluorescent and fluorogenic 2',7'-dialkylfluorescein derivatives and associated nonfluorescent precursor compounds; malignancy, multidrug resistance, lysosome storage disease, corneal acidosis, ulcer disease, diabetic heart condition, or hyperglycemia |
| 03/19/2009 | WO2009036106A1 Cytotoxic xanthone compounds |
| 03/19/2009 | WO2009034457A1 Organic compounds useful for the treatment of neurodegenerative diseases, uses and methods for the preparation thereof |
| 03/19/2009 | WO2009008980A3 Tetrahydropyranochromene gamma secretase inhibitors |
| 03/19/2009 | WO2008157552A3 Invertebrate acetylcholinesterase inhibitors |
| 03/19/2009 | US20090076276 such as (R)-3-(3-hydroxypyrrolidin-1-yl)-N-methyl-N-methoxypropanamide; poly(ADP-ribose)polymerase inhibitors |
| 03/19/2009 | US20090076130 Compounds for the inhibition of histone deacetylase |
| 03/19/2009 | US20090075908 Agent For Strengthening Calcium Containing Tissue and Use Thereof |
| 03/19/2009 | US20090075253 Bioreactive agents |
| 03/19/2009 | US20090074673 Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques |
| 03/18/2009 | EP2036897A1 Stable rhodamine labeling reagent |
| 03/18/2009 | EP2036601A1 Method for obtaining polyphenol-rich cocoa powder with a low fat content and cocoa thus obtained |
| 03/18/2009 | EP2036547A2 Treatment for Attention-Deficit Hyperactivity Disorder |
| 03/18/2009 | EP1768945B1 Substituted hydroxyacetophenon derivatives |
| 03/18/2009 | EP1558603A4 Oxyge-containing heterocyclic fused naphthopyrans |
| 03/18/2009 | CN101389614A Process for production of 3-{5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl}propionate ester and intermediate for the process |
| 03/18/2009 | CN101389600A Optical isomers of dihydro-2,3-benzodiazepine derivatives, process for their stereoselective synthesis |
| 03/18/2009 | CN101386806A Supercritical CO2 extraction of grape-kernel oil and method for extracting oligoprotoanthocyanidin by solvent process |
| 03/18/2009 | CN101386631A Technique for extracting and separating tea polyphenol from tea-leaf |
| 03/18/2009 | CN101386615A Method for extracting procyanidine from sea-buckthorn seed |
| 03/18/2009 | CN101386614A Method for preparing epigallocatechin-3-gallate by resin adsorption method |
| 03/18/2009 | CN101386613A Technique for extracting isoflavones materials from red clover |
| 03/18/2009 | CN101386612A Compounds with 3-phenyl-7-hydroxyl tonka bean camphor structure and medicinal use thereof |
| 03/18/2009 | CN100469774C Ginkgo leaf extract and separation production process of high purity effective component of the extract |
| 03/18/2009 | CN100469773C Preparation method and usage for nitrogen-containing flavone derivatives |
| 03/17/2009 | US7504496 Water-soluble rhodamine dye conjugates |
| 03/17/2009 | US7504395 Treatment for attention-deficit hyperactivity disorder |
| 03/17/2009 | CA2717039A1 Catalytic process for asymmetric hydrogenation |
| 03/17/2009 | CA2316351C Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |
| 03/12/2009 | WO2009031709A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031708A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031706A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031195A1 Composition containing flavanone compound monomer |
| 03/12/2009 | US20090069415 Deuterium-enriched nebivolol |
| 03/12/2009 | US20090069414 Epicatechin and vasodilation |
| 03/12/2009 | US20090068751 Methods of Labelling Polynucleotides with Dibenzorhodamine Dyes |
| 03/11/2009 | EP2032552A1 Mesogenic compounds, liquid crystal medium and liquid crystal display |
| 03/11/2009 | CN101384578A Radioligands for the 5 -ht1b receptor |
| 03/11/2009 | CN101384577A Novel coumarin derivative having antitumor activity |
| 03/11/2009 | CN101381420A Continuous extraction method of pectin, tannin and pigment from persimmon exocarp |
| 03/11/2009 | CN101381360A Grafts of plant polyphenol and weathered coal humic acid degradation product and grafting method |
| 03/11/2009 | CN101381359A Method for extracting high-purity epigallocatechin-3-gallate from green tea |
| 03/11/2009 | CN101381358A 8-methyl-benzopyran-2-one and synthetic method thereof and agricultural biological activity |
| 03/11/2009 | CN101381357A 4-bromomethyl-5,7-dihydroxy-benzopyran-2-one and synthetic method thereof and agricultural biological activity |
| 03/11/2009 | CN101380379A Total flavone in leaves of Murraya paniculata (L.) Jack and preparation method and use thereof |
| 03/11/2009 | CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 03/05/2009 | WO2009026657A1 Flavonoid ppar agonists |
| 03/05/2009 | US20090062555 Synthesis of Isoflavone |
| 03/05/2009 | US20090062543 Uv excitable fluorescent energy transfer dyes |
| 03/04/2009 | EP2029611A2 17-desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents etc. |
| 03/04/2009 | EP2029568A1 Flavonoid dimers and methods of making and using such |
| 03/04/2009 | EP2029567A1 Process for the production of benzopyran-2-ol derivatives |
| 03/04/2009 | EP2028938A1 3,4-disubstituted coumarin and quinolone compounds |
| 03/04/2009 | CN101379051A Method for preparing prostaglandin derivative |
| 03/04/2009 | CN101376866A Rhus chinensis fruit steam-explosion treatment and comprehensive utilization technology of lipid and flavone thereof |
| 03/04/2009 | CN101376653A Flavonol compound, and preparation and use thereof |
| 03/03/2009 | US7498358 Human ADAM-10 inhibitors |
| 03/03/2009 | CA2450501C Asymmetric benzoxanthene dyes |
| 02/26/2009 | WO2009026252A1 Methods for assaying alpha-l-iduronidase enzymatic activity |
| 02/26/2009 | WO2009026176A2 Antiinfective flavononol compounds and methods of use thereof |
| 02/26/2009 | WO2009024087A1 An uv-assisted method for surface modification and products having surface formed thereby |
| 02/26/2009 | WO2008150085A3 3',4',5-trimethoxy flavone derivatives as stimulant of mucus secretion, method of the same, and pharmaceutical composition comprising the same |
| 02/26/2009 | US20090054518 AMPelopsin Unsaturated Sodium Salt Preparation and Applications thereof |
| 02/26/2009 | US20090054516 Composition for treating cancer cells and synthetic method for the same |
| 02/26/2009 | US20090054506 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 02/26/2009 | US20090053818 Quantitative proteomics with isotopic substituted raman active labeling |
| 02/26/2009 | US20090053641 Charge control agent and related art |
| 02/26/2009 | CA2696753A1 Antiinfective flavononol compounds and methods of use thereof |
| 02/25/2009 | EP2027104A1 Arylsulfonylchromans as 5-ht6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors |
| 02/25/2009 | EP2027103A1 New chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof |
| 02/25/2009 | CN101374803A Cyclic amine derivatives and their uses |
| 02/25/2009 | CN101372482A Synthesis and use of luciferin calcium ion indicator |
| 02/25/2009 | CN100463906C Extraction method for daphnoretin |